Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|93|5|402-408

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.5, 2013-05, pp. : 402-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 5, 2014-11 ,pp. : 542-548

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 349-349

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interpreting the CYP2D6 Results From the International Tamoxifen Pharmacogenetics Consortium

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 2, 2014-08 ,pp. : 144-146

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased carrier prevalence of deficient CYP2C9, CYP2C19 and CYP2D6 alleles in depressed patients referred to a tertiary psychiatric hospital

By Ruañño Gualberto   Villagra David   Rahim Umme Salma   Windemuth Andreas   Kocherla Mohan   Bower Bruce   Szarek Bonnie L   Goethe John W  

Personalized Medicine, Vol. 5, Iss. 6, 2008-11 ,pp. : 579-587

Future Medicine

Access to resources Recommend Favorite

Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed‐function oxidase system, in the metabolism of psychotropic drugs

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 167-177

John Wiley & Sons Inc

Access to resources Recommend Favorite